FLNA is Filana Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.82. Market cap: $40M.
Stock snapshot
| Price | $0.82 |
| Market cap | $40M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About FLNA
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Related non-dividend companies
Other non-dividend stocks investors research alongside FLNA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is FLNA's current stock price?
FLNA (Filana Therapeutics, Inc.) is currently trading at $0.82.
Does FLNA pay a dividend?
FLNA (Filana Therapeutics, Inc.) does not currently pay a regular dividend.
Track FLNA in DiviDrip
Add FLNA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search FLNA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.